HomeUSABioStar Capital Closes Fund V, at $130.3M

BioStar Capital Closes Fund V, at $130.3M

BioStar Capital

BioStar Capital, a Petoskey, Mich.-based strategic venture capital firm focusing on medical technologies, closed its fifth fund, at $130.3m.

Led by founder Louis Cannon, M.D., a cardiovascular physician, innovator, and educator, as well as Alan Davis, M.D., orthopedic surgeon, now Emeritus Staff at The Cleveland Clinic, BioStar focuses on such fields as:

  • cardiovascular disease,
  • orthopedics, and
  • robotics.

The firm expects to invest in 8-10 additional companies over the next five years.

BioStar Capital’s Fund V portfolio includes some of today’s most innovative medical device companies:

  • Amplitude Vascular Systems (AVS), developing an intravascular lithotripsy device for treating heavily calcified arteries;
  • Medical Microinstruments (MMI), which has commercialized its robotic device that permits doctors to operate at microsurgical levels for precision reconstruction of small blood vessels, nerves and lymphatics using the world’s smallest wristed surgical instruments;
  • REVA Medical, which has developed the MOTIV Bioresorbable Scaffold that is designed to treat below-the-knee peripheral artery disease and obtained CE Mark approval for treating this disease; and
  • Versa Vascular, currently developing a non-tissue, non-mechanical, catheter-delivered implant for treating tricuspid valve regurgitation.